timolol has been researched along with bimatoprost in 92 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 44 (47.83) | 29.6817 |
| 2010's | 39 (42.39) | 24.3611 |
| 2020's | 9 (9.78) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Cantor, LB | 1 |
| Brandt, JD; Chen, K; VanDenburgh, AM; Whitcup, SM | 1 |
| Brandt, J; Sherwood, M | 1 |
| Batoosingh, A; Cheetham, J; David, R; Felix, C; Laibovitz, RA; Rosenthal, A; VanDenburgh, AM | 1 |
| Camras, CB | 1 |
| Easthope, SE; Perry, CM | 1 |
| Robin, AL | 1 |
| Camras, CB; Eisenberg, DL; Toris, CB | 1 |
| Chen, K; Goldberg, I; Gross, RL; Higginbotham, EJ; Schuman, JS; VanDenburgh, AM; Whitcup, SM | 1 |
| Cantor, LB; Chen, K; VanDenburgh, AM; Whitcup, SM | 1 |
| Agarwal, HC; Gupta, V; Sihota, R | 1 |
| Bernstein, P; Coleman, AL; Lerner, F; Whitcup, SM | 1 |
| Carpenter, SP; DuBiner, HB; Khan, B; VanDenburgh, AM; Walters, TR | 1 |
| Bernstein, P; Cheetham, JK; Cohen, JS; Gross, RL; VanDenburgh, AM; Whitcup, SM | 1 |
| Bucci, MG; Centofanti, M; Manni, G; Oddone, F; Parravano, M | 1 |
| Tressler, CS | 1 |
| Garcia-Feijoo, J; Garcia-Sanchez, J; Larrosa, JM; Martin, E; Martinez-de-la-Casa, JM; Troyano, J | 1 |
| Aagren, M; Buchholz, P; Holmstrom, S; Walt, J; Wickstrøm, J | 2 |
| Goldberg, LD; Walt, J | 1 |
| Baudouin, C; Bron, AM; Creuzot-Garcher, C; Lizard, G; Malvitte, L; Montange, T; Vejux, A | 1 |
| Soto, J | 1 |
| Chen, XM; Li, N; Wei, ML; Yao, X; Zhou, Y | 1 |
| Ermis, SS; Inan, UU; Ozturk, F | 1 |
| Boehm, A; Centofanti, M; Goldblum, D; Karabatsas, CH; Rossetti, L; Topouzis, F; Vetrugno, M; Viswanathan, A; Vorwerk, C | 1 |
| Martinez, A; Sanchez, M | 3 |
| Küsbeci, T; Oztürk, F; Yavas, GF | 1 |
| Konstas, AG; Kruft, B; Nelson, LA; Stewart, WC | 1 |
| Buchholz, P; Ferreras, A; Friis, MM; Gouws, P; Hommer, A; Steeds, C; Thygesen, J; Wickstrøm, J | 1 |
| Batoosingh, AL; Cohen, JS; Gross, RL; Liu, CC; Safyan, E; Williams, RD | 1 |
| Nelson, LA; Sharpe, ED; Stewart, JA; Stewart, WC; Williams, RD | 1 |
| Skorkovská, K | 1 |
| Bhardwaj, N; Gupta, S; Singh, H; Thakur, AS | 1 |
| Martínez, A; Slof, J | 1 |
| Călugăru, D; Călugăru, M | 3 |
| Curran, MP; Orman, JS | 1 |
| Buchholz, P; Feuerhake, C; Kimmich, F | 1 |
| Cai, JP; Cheng, JW; Wei, RL | 1 |
| Jamshidian-Tehrani, M; Mehdizadeh, M; Nowroozzadeh, MH | 1 |
| Laxmana Rao, HB; Sekhar, GC | 1 |
| Embeslidis, T; Georgiadou, I; Haidich, AB; Holló, G; Irkec, M; Konstas, AG; Melamed, S; Mikropoulos, D; Tsironi, S | 1 |
| Batoosingh, AL; Gross, RL; Lewis, RA; Liu, CC; Sall, KN; Schiffman, RM | 1 |
| de Moraes, CG; Facio, AC; Hatanaka, M; Reis, AS; Susanna, R; Suzuki, R; Vidal, KS | 1 |
| Boehm, A; Centofanti, M; Gandolfi, S; Haustein, M; Hommer, A; Manni, G; Oddone, F; Rossetti, L; Sangermani, C; Sportelli, V; Tanga, L | 1 |
| García-Pérez, JL; González-Gordaliza, C; Muñoz-Negrete, FJ; Puerto-Hernández, B; Rebolleda Fernández, G | 1 |
| Della Paolera, M; Giampani, J; Lottenberg, CL; Mendonça, M; Paranhos, A; Russ, H; Silva, MJ; Torres, RJ | 1 |
| Aydin, N; Erbil, HH; Mesci, C | 1 |
| Dastiridou, AI; Fanariotis, M; Katsanos, A; Kotoula, M; Tsironi, EE | 1 |
| Liehneova, I; Negrete, FJ; Scherzer, ML; Schnober, D | 1 |
| Babić, N; Camara, C; Cieślińska, I; Ferkova, S; Holló, G; Januleviciene, I; Kaluzny, BJ; Kóthy, P; Kozobolis, V; Kristoffersen, MS; Krzyzanowska-Berkowska, P; Mikropoulos, DG; Misiuk-Hojlo, M; Nelson, LA; Quaranta, L; Russo, A; Stewart, JA; Stewart, WC; Teus, MA; Thelen, U | 1 |
| Cojocaru, I; Pop, A; Stefan, C | 1 |
| Balbaba, M; Çelebi, S; Ulaş, F | 1 |
| Dimopoulos, AT; Empeslidis, T; Haidich, AB; Holló, G; Konstas, AG; Mikropoulos, DG; Ritch, R; Teus, MA | 1 |
| Nixon, DR | 1 |
| Barros, Jde N; Faria, NV; Gomes, JÁ; Mello, PA; Montiani-Ferreira, F; Nogueira-Filho, PA; Russ, HH | 1 |
| Choi, CY; Kim, CY; Kim, JM; Shim, SH | 1 |
| Chen, X; Dong, Y; Fang, A; Hu, Y; Ling, Z; Liu, D; Sun, W; Sun, X; Wang, Y; Xing, Y; Ye, J; Yin, Z; Zhang, M | 1 |
| Abegāo Pinto, L; Lequeu, I; Stalmans, I; Theuwis, K; Vandewalle, E | 1 |
| Bautista, D; Chew, PT; Khoo, AL; Lim, BP; Lin, L; Sng, CC; Teng, M; Wong, HT; Wu, TS; Yip, LW; Zhao, YJ | 1 |
| Kumar, MS; Mishra, D; Sinha, BP | 1 |
| García-López, A; Hartleben, C; Jiménez-Román, J; Paczka, JA | 1 |
| Boehm, A; Centofanti, M; Fogagnolo, P; Goldblum, D; Karabatsas, CH; Rossetti, L; Sacchi, M; Topouzis, F; Vetrugno, M; Vorwerk, C | 1 |
| Holló, G; Kóthy, P | 1 |
| Cheng, JW; Lou, H; Wang, H; Wei, RL; Zong, Y | 1 |
| Fang, Y; Ling, Z; Sun, X | 1 |
| Mansouri, K; Medeiros, FA; Weinreb, RN | 1 |
| Berardo, F; Centofanti, M; Ferrazza, M; Manni, G; Michelessi, M; Oddone, F; Roberti, G; Rossetti, L; Tanga, L | 1 |
| Nucci, P; Sacchi, M; Specchia, C; Villani, E; Williams, SE | 1 |
| Alster, Y; Benza, R; Brandt, JD; DuBiner, H; Sall, K; Semba, CP; Walker, G | 1 |
| Selen, F; Tekeli, O; Yanık, Ö | 1 |
| Karaśkiewicz, J; Lubiński, W; Mularczyk, M; Penkala, K | 1 |
| Akyol, N; Imamoglu, HI; Kalkisim, A; Kola, M; Turk, A | 1 |
| Ates, H; Degirmenci, C; Guven Yilmaz, S; Karakoyun, YE; Yusifov, E | 1 |
| Agnifili, L; Brescia, L; Fasanella, V; Mastropasqua, L; Mastropasqua, R; Oddone, F; Scatena, B | 1 |
| Samuelson, TW | 1 |
| Carleton, B; Etminan, M; Mikelberg, FS; Wendel, C; Zakrzewski, H | 1 |
| Brown, GC; Brown, MM | 1 |
| Bourne, RRA; Kaarniranta, K; Lorenz, K; Ropo, A; Traverso, CE; Vuorinen, J | 1 |
| Belfort, R; Chen, MY; Della Paolera, M; Goodkin, ML; Kim, T; Lopes Silva, MJ; Paula, JS | 1 |
| Huang, S; Xing, Y; Zhang, K; Zhu, L | 1 |
| Ciganov, AZ; Dorofeev, DA; Kryzhanovskaya, AV | 1 |
| Desai, AR; Desai, DM; Maulvi, FA; Ranch, KM; Sandeman, S; Shah, DO; Shah, SA; Shukla, MR; Vyas, BA | 1 |
| Bejanian, M; Coote, M; Goodkin, ML; Guo, Q; Kolko, M; Medeiros, FA; Robinson, MR; Walters, TR; Weinreb, RN; Zhang, J | 1 |
| Barbeau, M; Beauchemin, C; Cui, AX; Harasymowycz, P; Jobin-Gervais, K; Lachaine, J; Mathurin, K; Royer, C | 1 |
| Bacharach, J; Bejanian, M; Belalcázar, S; Chen, MY; Ferguson, G; Goodkin, ML; Guo, Q; Liu, J; Robinson, MR; Tatham, A; Thieme, H; Wirta, DL | 1 |
| Barbosa, GCS; Lima, VL; Mota, RT; Susanna, BN; Susanna, CN; Susanna, FN; Susanna, R | 1 |
| Fassari, C; Holló, G; Kirwan, J; Lopez-Lopez, F; Oddone, F; Zimina, M | 1 |
20 review(s) available for timolol and bimatoprost
| Article | Year |
|---|---|
Bimatoprost: a member of a new class of agents, the prostamides, for glaucoma management.
Topics: Amides; Bimatoprost; Clinical Trials as Topic; Cloprostenol; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Lipids; Prostaglandins F, Synthetic; Timolol | 2001 |
Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
Topics: Administration, Topical; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Conjunctival Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glaucoma, Open-Angle; Intraocular Pressure; Latanoprost; Lipids; Ocular Hypertension; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2002 |
Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Lipids; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost | 2002 |
Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma.
Topics: Adrenergic beta-Antagonists; Adult; Amides; Bimatoprost; Clinical Trials as Topic; Cloprostenol; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Lipids; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost; Treatment Outcome | 2005 |
Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications.
Topics: Adrenergic beta-Antagonists; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Cost-Benefit Analysis; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Lipids; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol; Treatment Outcome; United States | 2006 |
Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
Topics: Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Dinoprost; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Lipids; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost | 2006 |
Efficacy and safety of bimatoprost/timolol fixed combination in the treatment of glaucoma or ocular hypertension.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Blood Pressure; Cloprostenol; Drug Combinations; Glaucoma; Humans; Lipids; Ocular Hypertension; Timolol; Treatment Outcome | 2008 |
Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Single-Blind Method; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2008 |
[Cost-efficacy analysis of fixed combinations of prostaglandin/prostamide for treating glaucoma].
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Cost-Benefit Analysis; Drug Combinations; Glaucoma; Humans; Latanoprost; Middle Aged; Prostaglandins F, Synthetic; Timolol; Travoprost | 2008 |
[Fixed combinations of glaucoma medications].
Topics: Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Cloprostenol; Drug Combinations; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Travoprost; Treatment Outcome | 2008 |
Bimatoprost/timolol: a review of its use in glaucoma and ocular hypertension.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Clinical Trials as Topic; Cloprostenol; Cost-Benefit Analysis; Drug Combinations; Glaucoma; Humans; Latanoprost; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol | 2009 |
Meta-analysis of medical intervention for normal tension glaucoma.
Topics: Aged; Amides; Antihypertensive Agents; Betaxolol; Bimatoprost; Brimonidine Tartrate; Cloprostenol; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Quinoxalines; Randomized Controlled Trials as Topic; Sulfonamides; Thiazines; Thiophenes; Timolol; Tonometry, Ocular; Travoprost | 2009 |
[Bimatoprost therapy in glaucoma].
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Therapy, Combination; Evidence-Based Medicine; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost; Treatment Outcome | 2009 |
[The latest developments in glaucoma therapy using fixed combination products].
Topics: Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate, Timolol Maleate Drug Combination; Carbonic Anhydrase Inhibitors; Cloprostenol; Drug Combinations; Drug Therapy, Combination; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Thiophenes; Timolol; Travoprost; Treatment Outcome | 2011 |
[Fixed combination of topical prostaglandin analogue in glaucoma treatment].
Topics: Amides; Antihypertensive Agents; Bimatoprost; Carbonic Anhydrase Inhibitors; Cloprostenol; Drug Combinations; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Optic Nerve; Prostaglandins F, Synthetic; Prostaglandins, Synthetic; Sulfonamides; Thiazines; Timolol; Travoprost; Treatment Outcome; Visual Fields | 2011 |
Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F; Prostaglandins F, Synthetic; Prostaglandins, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost | 2014 |
Efficacy and tolerability of prostaglandin-timolol fixed combinations: an updated systematic review and meta-analysis.
Topics: Antihypertensive Agents; Bimatoprost; Drug Combinations; Glaucoma; Humans; Hyperemia; Intraocular Pressure; Latanoprost; Prostaglandins F, Synthetic; Timolol; Travoprost | 2015 |
Fixed-combination treatments for intraocular hypertension in Chinese patients - focus on bimatoprost-timolol.
Topics: Adrenergic beta-Antagonists; Asian People; Bimatoprost; China; Drug Combinations; Glaucoma; Humans; Ocular Hypertension; Timolol | 2015 |
The efficacy of the fixed combination of latanoprost and timolol versus other fixed combinations for primary open-angle glaucoma and ocular hypertension: A systematic review and meta-analysis.
Topics: Antihypertensive Agents; Bimatoprost; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Sulfonamides; Thiophenes; Timolol; Travoprost; Treatment Outcome | 2020 |
Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis.
Topics: Amides; Antihypertensive Agents; Bayes Theorem; Betaxolol; Bimatoprost; Brimonidine Tartrate; Carteolol; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Network Meta-Analysis; Ocular Hypertension; Prostaglandins A; Prostaglandins F, Synthetic; Timolol; Travoprost | 2022 |
47 trial(s) available for timolol and bimatoprost
| Article | Year |
|---|---|
Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP : a 3-month clinical trial.
Topics: Adult; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Double-Blind Method; Drug Administration Schedule; Female; Glaucoma; Hemodynamics; Humans; Intraocular Pressure; Lipids; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Safety; Timolol; Treatment Outcome; Visual Acuity; Visual Fields | 2001 |
Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure.
Topics: Adrenergic beta-Antagonists; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Conjunctiva; Double-Blind Method; Eye Color; Female; Glaucoma; Humans; Hyperemia; Intraocular Pressure; Iris; Lipids; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Safety; Timolol | 2001 |
Comparison of the ocular hypotensive lipid AGN 192024 with timolol: dosing, efficacy, and safety evaluation of a novel compound for glaucoma management.
Topics: Adult; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Female; Hemodynamics; Humans; Intraocular Pressure; Lipids; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Safety; Timolol | 2001 |
Bimatoprost vs. timolol.
Topics: Adrenergic beta-Antagonists; Amides; Antihypertensive Agents; Bimatoprost; Clinical Trials as Topic; Cloprostenol; Glaucoma; Humans; Intraocular Pressure; Lipids; Ophthalmic Solutions; Timolol | 2002 |
One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Amides; Bimatoprost; Cloprostenol; Double-Blind Method; Drug Administration Schedule; Female; Glaucoma; Humans; Hyperemia; Intraocular Pressure; Lipids; Male; Middle Aged; Ocular Hypertension; Safety; Timolol; Treatment Outcome | 2002 |
A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension.
Topics: Adult; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Double-Blind Method; Drug Administration Schedule; Female; Glaucoma; Humans; Intraocular Pressure; Lipids; Male; Middle Aged; Ocular Hypertension; Timolol; Treatment Outcome | 2003 |
Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Amides; Bimatoprost; Chronic Disease; Cloprostenol; Drug Therapy, Combination; Eye; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lipids; Male; Middle Aged; Pilocarpine; Prospective Studies; Pulsatile Flow; Regional Blood Flow; Single-Blind Method; Timolol; Treatment Outcome | 2003 |
A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Double-Blind Method; Drug Combinations; Female; Glaucoma; Humans; Intraocular Pressure; Lipids; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Safety; Sulfonamides; Thiophenes; Timolol | 2003 |
24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Double-Blind Method; Drug Therapy, Combination; Female; Gels; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Lipids; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2004 |
Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lipids; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Safety; Timolol | 2004 |
A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients.
Topics: Adult; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Lipids; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Safety; Single-Blind Method; Timolol; Treatment Outcome | 2004 |
A 6-month assessment of bimatoprost 0.03% vs timolol maleate 0.5%: hypotensive efficacy, macular thickness and flare in ocular-hypertensive and glaucoma patients.
Topics: Adult; Amides; Anterior Chamber; Antihypertensive Agents; Bimatoprost; Cloprostenol; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lipids; Macula Lutea; Ocular Hypertension; Prospective Studies; Timolol; Treatment Outcome | 2007 |
Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study.
Topics: Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lipids; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Single-Blind Method; Sulfonamides; Thiophenes; Timolol | 2007 |
Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
Topics: Aged; Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Lipids; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Treatment Outcome | 2007 |
A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Lipids; Male; Middle Aged; Prostaglandins F, Synthetic; Single-Blind Method; Timolol; Treatment Outcome | 2007 |
The effect of ocular hypotensive agents on macula.
Topics: Administration, Topical; Adult; Aged; Amides; Bimatoprost; Cloprostenol; Drug Administration Schedule; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Latanoprost; Lipids; Macula Lutea; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Travoprost; Visual Acuity; Visual Field Tests | 2007 |
Bimatoprost/timolol fixed combination vs latanoprost/timolol fixed combination in open-angle glaucoma patients.
Topics: Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Cross-Over Studies; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Timolol | 2009 |
Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.
Topics: Amides; Analysis of Variance; Bimatoprost; Cloprostenol; Conjunctival Diseases; Double-Blind Method; Drug Administration Schedule; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Timolol; Treatment Outcome; Visual Acuity | 2008 |
A comparison of dorzolamide/timolol-fixed combination versus bimatoprost in patients with open-angle glaucoma who are poorly controlled on latanoprost.
Topics: Aged; Aged, 80 and over; Amides; Bimatoprost; Cloprostenol; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Latanoprost; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2008 |
[Comparison of intraocular pressure lowering efficacy of bimatoprost / timolol fixed combination and other glaucoma medications in the treatment of glaucoma].
Topics: Adult; Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Combinations; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Middle Aged; Ocular Hypotension; Prostaglandins F, Synthetic; Timolol; Travoprost | 2008 |
Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucoma.
Topics: Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Cross-Over Studies; Drug Administration Schedule; Drug Combinations; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Single-Blind Method; Timolol; Treatment Outcome | 2010 |
The safety and efficacy of bimatoprost/timolol fixed combination: a 1-year double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension.
Topics: Adult; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Timolol; Tonometry, Ocular; Treatment Outcome | 2010 |
A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Blood Pressure; Cloprostenol; Drug Combinations; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol | 2009 |
Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination.
Topics: Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Cross-Over Studies; Double-Blind Method; Drug Combinations; Glaucoma, Open-Angle; Gonioscopy; Humans; Intraocular Pressure; Latanoprost; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Travoprost; Visual Acuity | 2010 |
[Evaluation of the effect of bimatoprost/timolol fixed combination on ocular blood flow in patients with ocular hypertension using colour Doppler imaging. Preliminary study].
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Double-Blind Method; Drug Combinations; Eye; Female; Humans; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Regional Blood Flow; Timolol; Ultrasonography, Doppler, Color | 2010 |
Twenty-four-hour intraocular pressure control with latanoprost-timolol-fixed combination versus bimatoprost in patients who switched from timolol.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Treatment Outcome; Vision Disorders; Visual Fields | 2011 |
Travoprost 0.004%/timolol 0.5% fixed combination in patients transitioning from fixed or unfixed bimatoprost 0.03%/timolol 0.5%.
Topics: Adult; Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Combinations; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Timolol; Travoprost | 2011 |
Effect of prophylactic intraocular pressure-lowering medication on pain during cataract surgery.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Cataract; Cloprostenol; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Pain; Phacoemulsification; Postoperative Period; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Travoprost | 2013 |
24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma.
Topics: Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Cross-Over Studies; Double-Blind Method; Drug Combinations; Exfoliation Syndrome; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Treatment Outcome; Visual Field Tests; Visual Fields | 2013 |
A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressure.
Topics: Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Cross-Over Studies; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Hyperemia; Intraocular Pressure; Latanoprost; Male; Middle Aged; Patient Preference; Prospective Studies; Prostaglandins F, Synthetic; Single-Blind Method; Timolol; Travoprost; Treatment Outcome | 2013 |
Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial.
Topics: Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Combinations; Eye; Female; Glaucoma, Open-Angle; HLA-DR Antigens; Humans; Immunohistochemistry; Interleukin-6; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Prostaglandins, Synthetic; Single-Blind Method; Timolol; Travoprost; Treatment Outcome | 2013 |
Diurnal intraocular pressure with bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in healthy subjects.
Topics: Adult; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Healthy Volunteers; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Treatment Outcome | 2014 |
Safety and efficacy of bimatoprost/timolol fixed combination in Chinese patients with open-angle glaucoma or ocular hypertension.
Topics: Adolescent; Adult; Aged; Amides; Bimatoprost; Cloprostenol; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Ocular Hypertension; Timolol; Young Adult | 2014 |
Long term IOP lowering efficacy of bimatoprost/timolol fixed combination: a 12 month prospective study.
Topics: Aged; Amides; Bimatoprost; Cloprostenol; Drug Combinations; Female; Humans; Intraocular Pressure; Ocular Hypertension; Prospective Studies; Timolol; Treatment Outcome | 2013 |
Comparing the efficacy of latanoprost (0.005%), bimatoprost (0.03%), travoprost (0.004%), and timolol (0.5%) in the treatment of primary open angle glaucoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Bimatoprost; Blood Pressure; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome; Visual Acuity; Visual Field Tests; Visual Fields | 2014 |
Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
Topics: Administration, Topical; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Circadian Rhythm; Cloprostenol; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Treatment Outcome | 2014 |
Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial.
Topics: Adult; Aged; Amides; Analysis of Variance; Antihypertensive Agents; Bimatoprost; Blood Pressure; Cloprostenol; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol | 2015 |
Effect of glaucoma medications on 24-hour intraocular pressure-related patterns using a contact lens sensor.
Topics: Administration, Topical; Adult; Aged; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Circadian Rhythm; Contact Lenses; Cross-Over Studies; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Monitoring, Ambulatory; Ophthalmic Solutions; Prospective Studies; Sulfonamides; Thiazines; Timolol; Tonometry, Ocular; Young Adult | 2015 |
Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial.
Topics: Administration, Topical; Aged; Antihypertensive Agents; Bimatoprost; Blood Pressure; Circadian Rhythm; Double-Blind Method; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Timolol; Tonometry, Ocular; Treatment Outcome | 2015 |
Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Bimatoprost; Delayed-Action Preparations; Double-Blind Method; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Prospective Studies; Timolol; Tonometry, Ocular | 2016 |
Evaluation of the effects on choroidal thickness of bimatoprost 0.03% versus a brinzolamide 1.0%/timolol maleate 0.5% fixed combination.
Topics: Adult; Aged; Antihypertensive Agents; Bimatoprost; Choroid; Drug Combinations; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Middle Aged; Single-Blind Method; Sulfonamides; Thiazines; Timolol; Tomography, Optical Coherence | 2017 |
The efficacy and safety of bimatoprost/timolol maleate, latanoprost/timolol maleate, and travoprost/timolol maleate fixed combinations on 24-h IOP.
Topics: Aged; Aged, 80 and over; Bimatoprost; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Gonioscopy; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Monitoring, Physiologic; Prospective Studies; Prostaglandins F, Synthetic; Single-Blind Method; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2018 |
Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV study.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Bimatoprost; Drug Administration Schedule; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intention to Treat Analysis; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Preservatives, Pharmaceutical; Prostaglandins F; Quality of Life; Timolol | 2019 |
Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil
Topics: Aged; Antihypertensive Agents; Bimatoprost; Brazil; Brimonidine Tartrate; Double-Blind Method; Drug Combinations; Female; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Timolol | 2020 |
Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1).
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Bimatoprost; Double-Blind Method; Drug Implants; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Timolol; Tonometry, Ocular; Vitreous Body; Young Adult | 2020 |
Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2).
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Bimatoprost; Dose-Response Relationship, Drug; Double-Blind Method; Drug Implants; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Timolol; Young Adult | 2021 |
Intraocular Peak Pressure in Patients Under Treatment With Fixed Combination of Bimatoprost/Timolol/Brimonidine Once Daily Versus Twice Daily.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Double-Blind Method; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Timolol; Water | 2022 |
25 other study(ies) available for timolol and bimatoprost
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
An accurate comparison of bimatoprost's efficacy and adverse effects.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Clinical Trials as Topic; Cloprostenol; Humans; Intraocular Pressure; Lipids; Ocular Hypertension; Safety; Timolol | 2002 |
Bimatoprost versus timolol and dorzolamide.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Combinations; Glaucoma; Humans; Intraocular Pressure; Lipids; Ocular Hypertension; Ophthalmic Solutions; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes; Timolol | 2005 |
The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Controlled Clinical Trials as Topic; Cost-Benefit Analysis; Decision Trees; Drug Costs; Economics, Pharmaceutical; Europe; Glaucoma, Open-Angle; Health Care Costs; Humans; Intraocular Pressure; Latanoprost; Lipids; Models, Econometric; Prostaglandins F, Synthetic; Timolol | 2006 |
Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs.
Topics: Administration, Topical; Aged; Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Carteolol; Case-Control Studies; Chemokines; Cloprostenol; Cytokines; Dose-Response Relationship, Immunologic; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Lipids; Male; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Tears; Thiophenes; Timolol | 2007 |
Comments on The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Cost-Benefit Analysis; Europe; Glaucoma, Open-Angle; Humans; Latanoprost; Lipids; Prostaglandins F, Synthetic; Timolol | 2006 |
A cost-effectiveness analysis of fixed-combination therapies in patients with open-angle glaucoma: a European perspective.
Topics: Adrenergic beta-Antagonists; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Cost-Benefit Analysis; Decision Support Techniques; Drug Therapy, Combination; Europe; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Models, Economic; Prostaglandins F, Synthetic; Prostaglandins, Synthetic; Timolol; Travoprost | 2008 |
Carotid cavernous sinus fistula presenting with pulsating exophthalmos and secondary glaucoma.
Topics: Adult; Amides; Antihypertensive Agents; Bimatoprost; Carotid-Cavernous Sinus Fistula; Cloprostenol; Exophthalmos; Glaucoma; Humans; Male; Timolol | 2008 |
Efficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Administration Schedule; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Ocular Hypertension; Optic Disk; Timolol; Visual Fields | 2009 |
Corneal thickness and glaucoma medications.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Cornea; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Single-Blind Method; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2009 |
Relative efficacy of prostaglandins.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Single-Blind Method; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2009 |
Hyperemia reduction after administration of a fixed combination of bimatoprost and timolol maleate to patients on prostaglandin or prostamide monotherapy.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Combinations; Follow-Up Studies; Glaucoma; Humans; Hyperemia; Intraocular Pressure; Latanoprost; Longitudinal Studies; Prostaglandins F, Synthetic; Time Factors; Timolol; Travoprost | 2010 |
Bimatoprost and bimatoprost/timolol fixed combination in patients with open-angle glaucoma and ocular hypertension.
Topics: Aged; Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Drug Combinations; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Single-Blind Method; Timolol; Treatment Outcome | 2011 |
Long-term outcomes of prostaglandin analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in Europe.
Topics: Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Disease Progression; Drug Costs; Europe; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Retrospective Studies; Time Factors; Timolol; Travoprost; Treatment Outcome | 2011 |
Prostaglandin analogue-induced pigmentation of the skin of the nasal septum and nasal alae in a glaucoma patient.
Topics: Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Combinations; Eyelid Diseases; Glaucoma, Open-Angle; Humans; Male; Nasal Septum; Nose Diseases; Skin Pigmentation; Timolol | 2015 |
Efficacy of Bimatoprost Plus Timolol Fixed Combination in Open Angle Glaucoma Patients Previously Treated with Dorzolamide Plus Timolol Fixed Combination.
Topics: Aged; Antihypertensive Agents; Bimatoprost; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Ophthalmic Solutions; Retrospective Studies; Sulfonamides; Thiophenes; Time Factors; Timolol; Treatment Outcome | 2016 |
Assessment of the Anterior Chamber Flare and Macular Thickness in Patients Treated with Topical Antiglaucomatous Drugs.
Topics: Administration, Topical; Anterior Chamber; Antihypertensive Agents; Bimatoprost; Female; Glaucoma; Humans; Latanoprost; Macular Degeneration; Male; Middle Aged; Prostaglandins F, Synthetic; Timolol | 2017 |
Evaluation of retinal ganglion cell function after intraocular pressure reduction measured by pattern electroretinogram in patients with primary open-angle glaucoma.
Topics: Adult; Aged; Analysis of Variance; Antihypertensive Agents; Bimatoprost; Electroretinography; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Retinal Ganglion Cells; Timolol; Vision, Ocular; Visual Field Tests | 2017 |
Meibomian Gland Features and Conjunctival Goblet Cell Density in Glaucomatous Patients Controlled With Prostaglandin/Timolol Fixed Combinations: A Case Control, Cross-sectional Study.
Topics: Aged; Antihypertensive Agents; Bimatoprost; Case-Control Studies; Cell Count; Conjunctiva; Cross-Sectional Studies; Drug Combinations; Female; Glaucoma; Goblet Cells; Humans; Intraocular Pressure; Latanoprost; Male; Meibomian Glands; Microscopy, Confocal; Middle Aged; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Travoprost | 2018 |
Coincident cataract and glaucoma surgery in an anticoagulated patient: January consultation #1.
Topics: Aged; Anticoagulants; Antihypertensive Agents; Bimatoprost; Cardiovascular Diseases; Cataract; Cataract Extraction; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Timolol; Trabeculectomy; Visual Acuity; Visual Field Tests; Visual Fields; Warfarin | 2018 |
Association of Postoperative Topical Prostaglandin Analog or Beta-Blocker Use and Incidence of Pseudophakic Cystoid Macular Edema.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Bimatoprost; Case-Control Studies; Cataract; Cataract Extraction; Combined Modality Therapy; Female; Humans; Incidence; Intraocular Pressure; Latanoprost; Macular Edema; Male; Middle Aged; Postoperative Complications; Postoperative Period; Prostaglandins, Synthetic; Pseudophakia; Timolol; Travoprost | 2018 |
Patient Preference-Based Comparative Effectiveness and Cost-Utility Analysis of the Prostamides for Open-Angle Glaucoma.
Topics: Bimatoprost; Cost-Benefit Analysis; Glaucoma, Open-Angle; Health Care Costs; Humans; Intraocular Pressure; Latanoprost; Patient Preference; Prostaglandins F; Timolol; Travoprost; Visual Acuity | 2019 |
[Effectiveness of antihypertensive conservative-free therapy with fixed combination of bimatoprost and timolol (intermediate results)].
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Combinations; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Ocular Hypertension; Timolol; Treatment Outcome | 2020 |
Multiple drug delivery from the drug-implants-laden silicone contact lens: Addressing the issue of burst drug release.
Topics: Animals; Bimatoprost; Contact Lenses; Drug Carriers; Drug Implants; Drug Liberation; Hyaluronic Acid; Intraocular Pressure; Rabbits; Silicones; Surface Properties; Timolol | 2020 |
Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment.
Topics: Adult; Antihypertensive Agents; Bimatoprost; Drug Combinations; Glaucoma; Glaucoma, Open-Angle; Humans; Hyperemia; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prospective Studies; Prostaglandins A; Prostaglandins F; Timolol; Travoprost | 2022 |